Cita APA

A, N. R., F, T. A., & S, A. (2024). Risk-sharing agreement based on health outcomes for the treatment of moderate severe psoriasis with certolizumab pegol.

Citación estilo Chicago

A, Navarro Ruiz, Toledo Alberola F, y Aceituno S. Risk-sharing Agreement Based On Health Outcomes for the Treatment of Moderate Severe Psoriasis With Certolizumab Pegol. 2024.

Cita MLA

A, Navarro Ruiz, Toledo Alberola F, y Aceituno S. Risk-sharing Agreement Based On Health Outcomes for the Treatment of Moderate Severe Psoriasis With Certolizumab Pegol. 2024.